HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENLIUS

64.700

-1.050-1.60%

Volume:35.80K

Turnover:2.34M

Market Cap:35.16B

PE:38.89

High:66.050

Open:65.850

Low:64.700

Close:65.750

52wk High:92.000

52wk Low:15.200

Shares:543.49M

HK Float Shares:163.43M

Volume Ratio:0.24

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.664

ROE:27.54%

ROA:4.97%

PB:9.36

PE(LYR):38.89

PS:5.50

Loading ...

Overview Company News Filings

Shanghai Henlius' IND Application for Cancer Therapy Gains China Approval; Shares Down 3%

MT Newswires Live

Shanghai Henlius Biotech (2696) Announces IND Approval for HLX37 Bispecific Antibody

Bulletin Express

HENLIUS (02696) Receives NMPA Approval for Phase 1 Clinical Trial of Self-Developed HLX37 in Advanced/Metastatic Solid Tumors

Shanghai Henlius Biotech Inc - Nmpa Approves Ind Application for Hlx37 in Advanced Solid Tumours

THOMSON REUTERS

Taikang Life Insurance Increases Stake in HENLIUS, Marking 37th Insurance Capital "Intervention" This Year

Shanghai Henlius Biotech (SEHK:2696): Evaluating Current Valuation Following Recent Share Price Fluctuations

Simply Wall St.

Henlius Biotech Doses First Patient in Hepatocellular Carcinoma Drug

MT Newswires Live

Taikang Insurance Group, Inc. Increases Stake in HENLIUS (02696) by 518,500 Shares at HK$67.07 per Share

Shanghai Henlius Biotech (2696) Announces First Patient Dosed in Phase 1 Trial of HLX13 for Unresectable HCC

Bulletin Express

HENLIUS (02696): First Patient Dosed in China for International Phase 1 Clinical Study of HLX13 (Ipilimumab Biosimilar) in First-Line Treatment of Unresectable Hepatocellular Carcinoma (HCC)

HK Stock Movement | HENLIUS (02696) Rises Over 6% in Afternoon Session as Serplulimab Included in NMPA's Breakthrough Therapy List

US September Nonfarm Payrolls Exceed Expectations, Third Rate Cut This Year Unlikely

HENLIUS (02696): Hansizhuang® (Serplulimab Injection) Combined with Chemotherapy for Gastric Cancer Neoadjuvant/Adjuvant Therapy Officially Included in NMPA's Breakthrough Therapy Designation Program

Shanghai Henlius Biotech Receives Breakthrough Therapy Designation for HANSIZHUANG in Gastric Cancer

Shanghai Henlius Biotech - Hansizhuang Granted Breakthrough Therapy Designation for Gastric Cancer by Nmpa

THOMSON REUTERS

Hong Kong Stocks Movement | HENLIUS (02696) Rises Over 4% as POHERDY Gains U.S. Approval, Covering All Indications of Reference Product

Organon, Shanghai Henlius Biotech Says FDA Clears Poherdy as Pertuzumab Biosimilar

MT Newswires Live

BUZZ-Organon rises after US FDA clears first biosimilar for breast cancer

FDA Approves Organon and Henlius' POHERDY as First Perjeta Biosimilar in US

Henlius Biotech Gets US FDA Nod for Breast Cancer Drug's Biologics License Application

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02696/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"HENLIUS","latestPrice":64.7,"timestamp":1765421208911,"preClose":65.75,"halted":0,"volume":35800,"delay":0,"floatShares":163428541,"shares":543494853,"eps":1.6635674217011809,"marketStatus":"Trading","change":-1.05,"latestTime":"12-11 10:47:20","open":65.85,"high":66.05,"low":64.7,"amount":2338275,"amplitude":0.020532,"askPrice":64.75,"askSize":300,"bidPrice":64.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.6713253542700668,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1765425600000},"marketStatusCode":2,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":65.75,"openAndCloseTimeList":[[1765416600000,1765425600000],[1765429200000,1765440000000]],"volumeRatio":0.235855,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02696\",,,,,undefined,":{"symbol":"02696","floatShares":163428541,"roa":"4.97%","roe":"27.54%","lyrEps":1.663567,"volumeRatio":0.235855,"shares":543494853,"dividePrice":0,"high":66.05,"amplitude":0.020532,"preClose":65.75,"low":64.7,"week52Low":15.2,"pbRate":"9.36","psRate":"5.50","week52High":92,"institutionHeld":0,"latestPrice":64.7,"committee":-0.5,"eps":1.6635674217011809,"divideRate":0,"volume":35800,"delay":0,"ttmEps":1.6713253542700668,"open":65.85,"prevYearClose":23.7,"prevWeekClose":67.55,"prevMonthClose":69.05,"prevQuarterClose":75.3,"fiveDayClose":67.45,"twentyDayClose":64.75,"sixtyDayClose":79.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02696\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null},{"date":"2025-03-24","symbol":"02696","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post Market","dateTimestamp":1742745600000,"actualEps":null},{"market":"HK","date":"2025-02-10","symbol":"02696","reason":null,"defaultRemindTime":1739151000000,"announcedDate":"2024-12-23","type":"delisting","dateTimestamp":1739116800000},{"market":"HK","date":"2024-08-26","symbol":"02696","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-21","symbol":"02696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710984600000,"name":null,"time":"","dateTimestamp":1710950400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1761753600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02696","date":"2025-12-10","current":38.711792,"percent":0.863526,"low":-39.586964,"twenty":-13.507065,"median":-7.563995,"eighty":22.81753,"high":139.007258,"avg":9.869354,"sd":37.00546,"marketCap":35734786584},"quantilePoints":[{"date":"2020-12-11","current":-18.813075,"twenty":-33.661797,"median":-28.517861,"eighty":-21.565285,"marketCap":22419162686},{"date":"2020-12-18","current":-19.579463,"twenty":-33.232461,"median":-28.420437,"eighty":-20.87362,"marketCap":23370278679},{"date":"2020-12-24","current":-19.900439,"twenty":-32.90058,"median":-28.320519,"eighty":-20.447832,"marketCap":23777899818},{"date":"2020-12-31","current":-21.347266,"twenty":-32.738825,"median":-28.072361,"eighty":-20.405196,"marketCap":25517083348},{"date":"2021-01-08","current":-20.007648,"twenty":-21.027696,"median":-20.057143,"eighty":-19.872325,"marketCap":24131171473},{"date":"2021-01-15","current":-18.953047,"twenty":-20.538983,"median":-19.867005,"eighty":-19.394728,"marketCap":22826783826},{"date":"2021-01-22","current":-19.863933,"twenty":-20.368146,"median":-19.863933,"eighty":-19.394728,"marketCap":23913773532},{"date":"2021-01-29","current":-17.730953,"twenty":-20.273574,"median":-19.738569,"eighty":-18.960572,"marketCap":21522396178},{"date":"2021-02-05","current":-17.567528,"twenty":-20.124621,"median":-19.454728,"eighty":-18.3532,"marketCap":21196299267},{"date":"2021-02-11","current":-18.846812,"twenty":-20.037345,"median":-19.387263,"eighty":-18.043904,"marketCap":22772434340},{"date":"2021-02-19","current":-17.894416,"twenty":-19.98484,"median":-18.965589,"eighty":-17.952934,"marketCap":21631095149},{"date":"2021-02-26","current":-17.122755,"twenty":-19.887674,"median":-18.91395,"eighty":-17.817431,"marketCap":20652804414},{"date":"2021-03-05","current":-17.481999,"twenty":-19.859226,"median":-18.774495,"eighty":-17.800508,"marketCap":21033250811},{"date":"2021-03-12","current":-17.195892,"twenty":-19.837295,"median":-18.44057,"eighty":-17.499595,"marketCap":20652804414},{"date":"2021-03-19","current":-16.86211,"twenty":-19.790352,"median":-18.12726,"eighty":-17.253113,"marketCap":20245183274},{"date":"2021-03-26","current":-17.181113,"twenty":-19.623559,"median":-18.062887,"eighty":-17.138564,"marketCap":20272358016},{"date":"2021-04-01","current":-19.512345,"twenty":-19.512345,"median":-18.076073,"eighty":-17.177529,"marketCap":22962657539},{"date":"2021-04-09","current":-18.271256,"twenty":-19.510182,"median":-18.12726,"eighty":-17.179679,"marketCap":21549570921},{"date":"2021-04-16","current":-18.363013,"twenty":-19.476333,"median":-18.248673,"eighty":-17.18998,"marketCap":21739794120},{"date":"2021-04-23","current":-19.645162,"twenty":-19.476333,"median":-18.226089,"eighty":-17.316751,"marketCap":23315929193},{"date":"2021-04-30","current":-19.040057,"twenty":-19.648003,"median":-18.297927,"eighty":-17.448129,"marketCap":22690910112},{"date":"2021-05-07","current":-17.965945,"twenty":-19.565472,"median":-18.363013,"eighty":-17.482435,"marketCap":21549570921},{"date":"2021-05-14","current":-18.113671,"twenty":-19.510182,"median":-18.274791,"eighty":-17.482435,"marketCap":21712619377},{"date":"2021-05-21","current":-18.357986,"twenty":-19.487135,"median":-18.274791,"eighty":-17.516465,"marketCap":22011541546},{"date":"2021-05-28","current":-18.986811,"twenty":-19.432718,"median":-18.278327,"eighty":-17.567256,"marketCap":22989832281},{"date":"2021-06-04","current":-18.085054,"twenty":-19.394728,"median":-18.274791,"eighty":-17.569054,"marketCap":21794143605},{"date":"2021-06-11","current":-17.838307,"twenty":-19.380637,"median":-18.278327,"eighty":-17.596682,"marketCap":21495221436},{"date":"2021-06-18","current":-16.028857,"twenty":-19.316527,"median":-18.226089,"eighty":-17.499595,"marketCap":19158193568},{"date":"2021-06-25","current":-17.449469,"twenty":-19.090843,"median":-18.120466,"eighty":-17.407752,"marketCap":20843027612},{"date":"2021-07-02","current":-17.434433,"twenty":-19.054867,"median":-18.089655,"eighty":-17.397323,"marketCap":20788678127},{"date":"2021-07-09","current":-16.265645,"twenty":-19.040057,"median":-18.074879,"eighty":-17.195892,"marketCap":19375591509},{"date":"2021-07-16","current":-15.969405,"twenty":-19.032975,"median":-18.040488,"eighty":-17.122755,"marketCap":19022319855},{"date":"2021-07-23","current":-15.856864,"twenty":-19.023636,"median":-18.026565,"eighty":-17.079749,"marketCap":18886446141},{"date":"2021-07-30","current":-14.666803,"twenty":-18.986811,"median":-17.998882,"eighty":-16.849549,"marketCap":17527709009},{"date":"2021-08-06","current":-14.588335,"twenty":-18.965589,"median":-17.945733,"eighty":-16.750714,"marketCap":17391835296},{"date":"2021-08-13","current":-14.52296,"twenty":-18.953047,"median":-17.911145,"eighty":-16.470265,"marketCap":17337485810},{"date":"2021-08-20","current":-13.520478,"twenty":-18.945494,"median":-17.88088,"eighty":-16.251298,"marketCap":15217855884},{"date":"2021-08-27","current":-12.980395,"twenty":-18.88847,"median":-17.842996,"eighty":-16.122732,"marketCap":14674361031},{"date":"2021-09-03","current":-12.734842,"twenty":-18.882406,"median":-17.809029,"eighty":-15.859736,"marketCap":14402613604},{"date":"2021-09-10","current":-13.373232,"twenty":-18.846812,"median":-17.803134,"eighty":-15.761703,"marketCap":15163506398},{"date":"2021-09-17","current":-12.138916,"twenty":-18.846135,"median":-17.730953,"eighty":-15.089723,"marketCap":13723245038},{"date":"2021-09-24","current":-11.82096,"twenty":-18.810911,"median":-17.571343,"eighty":-14.867281,"marketCap":13369973383},{"date":"2021-09-30","current":-11.757587,"twenty":-18.785539,"median":-17.567074,"eighty":-14.603567,"marketCap":13342798641},{"date":"2021-10-08","current":-10.872073,"twenty":-18.769634,"median":-17.476946,"eighty":-14.333569,"marketCap":12337333163},{"date":"2021-10-15","current":-12.085096,"twenty":-18.725638,"median":-17.441951,"eighty":-13.86094,"marketCap":13723245038},{"date":"2021-10-22","current":-11.832626,"twenty":-18.639753,"median":-17.36388,"eighty":-13.648942,"marketCap":13533021839},{"date":"2021-10-29","current":-12.004873,"twenty":-18.601961,"median":-17.24697,"eighty":-13.384811,"marketCap":13696070295},{"date":"2021-11-05","current":-11.842443,"twenty":-18.587887,"median":-17.177529,"eighty":-13.069878,"marketCap":13533021839},{"date":"2021-11-12","current":-13.238443,"twenty":-18.539285,"median":-17.121354,"eighty":-12.950721,"marketCap":15190681141},{"date":"2021-11-19","current":-13.755236,"twenty":-18.493787,"median":-17.09849,"eighty":-12.989283,"marketCap":15761350737},{"date":"2021-11-26","current":-15.860878,"twenty":-18.471737,"median":-16.981974,"eighty":-13.021471,"marketCap":18179902832},{"date":"2021-12-03","current":-12.565895,"twenty":-18.441097,"median":-16.849549,"eighty":-12.989283,"marketCap":14429788347},{"date":"2021-12-10","current":-13.678439,"twenty":-18.435344,"median":-16.791123,"eighty":-12.950721,"marketCap":15734175994},{"date":"2021-12-17","current":-13.900665,"twenty":-18.427924,"median":-16.72442,"eighty":-12.950721,"marketCap":15978748678},{"date":"2021-12-24","current":-12.068814,"twenty":-18.41961,"median":-16.57278,"eighty":-12.854432,"marketCap":13886293494},{"date":"2021-12-31","current":-10.392945,"twenty":-18.411685,"median":-16.313069,"eighty":-12.599684,"marketCap":11984061508},{"date":"2022-01-07","current":-10.408899,"twenty":-11.114507,"median":-10.603378,"eighty":-10.458171,"marketCap":11956886766},{"date":"2022-01-14","current":-10.645935,"twenty":-11.136014,"median":-10.825867,"eighty":-10.516719,"marketCap":12255808935},{"date":"2022-01-21","current":-11.846284,"twenty":-11.23402,"median":-10.950741,"eighty":-10.575568,"marketCap":13668895552},{"date":"2022-01-28","current":-10.719633,"twenty":-11.23402,"median":-10.92037,"eighty":-10.575568,"marketCap":12337333163},{"date":"2022-02-04","current":-10.961121,"twenty":-11.226983,"median":-10.955931,"eighty":-10.603378,"marketCap":12609080589},{"date":"2022-02-11","current":-11.151206,"twenty":-11.195149,"median":-10.961121,"eighty":-10.645935,"marketCap":12853653273},{"date":"2022-02-18","current":-10.838643,"twenty":-11.151206,"median":-10.933229,"eighty":-10.645935,"marketCap":12554731104},{"date":"2022-02-25","current":-10.531157,"twenty":-11.149804,"median":-10.879658,"eighty":-10.555938,"marketCap":12228634192},{"date":"2022-03-04","current":-10.223007,"twenty":-11.133246,"median":-10.844907,"eighty":-10.526339,"marketCap":11875362538},{"date":"2022-03-11","current":-8.809298,"twenty":-11.096591,"median":-10.772075,"eighty":-10.439214,"marketCap":10217703236},{"date":"2022-03-18","current":-8.973146,"twenty":-11.067899,"median":-10.693082,"eighty":-10.247041,"marketCap":10859027162},{"date":"2022-03-25","current":-9.408384,"twenty":-11.060746,"median":-10.645935,"eighty":-9.613254,"marketCap":11386217170},{"date":"2022-04-01","current":-8.944167,"twenty":-11.060302,"median":-10.579658,"eighty":-9.555081,"marketCap":10837287368},{"date":"2022-04-08","current":-9.101703,"twenty":-11.051173,"median":-10.532504,"eighty":-9.487781,"marketCap":11032945515},{"date":"2022-04-14","current":-8.829357,"twenty":-10.996229,"median":-10.520302,"eighty":-9.272441,"marketCap":10685108809},{"date":"2022-04-22","current":-8.439191,"twenty":-10.958109,"median":-10.475675,"eighty":-9.02764,"marketCap":10022045089},{"date":"2022-04-29","current":-9.033079,"twenty":-10.95245,"median":-10.408899,"eighty":-8.917879,"marketCap":10554670045},{"date":"2022-05-06","current":-7.41082,"twenty":-10.943736,"median":-10.392945,"eighty":-8.839536,"marketCap":8587218677},{"date":"2022-05-13","current":-7.364351,"twenty":-10.915716,"median":-10.223007,"eighty":-8.8007,"marketCap":8380690633},{"date":"2022-05-20","current":-7.968917,"twenty":-10.889999,"median":-9.98237,"eighty":-8.584099,"marketCap":9195932912},{"date":"2022-05-27","current":-7.542162,"twenty":-10.879658,"median":-9.877618,"eighty":-8.1017,"marketCap":8695917648},{"date":"2022-06-02","current":-7.839485,"twenty":-10.877545,"median":-9.647965,"eighty":-8.02985,"marketCap":9087233942},{"date":"2022-06-10","current":-8.770543,"twenty":-10.856339,"median":-9.531356,"eighty":-7.992051,"marketCap":10098134368},{"date":"2022-06-17","current":-8.742365,"twenty":-10.841148,"median":-9.348726,"eighty":-8.004315,"marketCap":10054654780},{"date":"2022-06-24","current":-8.23701,"twenty":-10.797885,"median":-9.166898,"eighty":-8.03147,"marketCap":9511159927},{"date":"2022-06-30","current":-8.326656,"twenty":-10.778323,"median":-9.060482,"eighty":-8.076162,"marketCap":9598119103},{"date":"2022-07-08","current":-8.497078,"twenty":-10.769546,"median":-8.973146,"eighty":-8.128672,"marketCap":9804647148},{"date":"2022-07-15","current":-8.681154,"twenty":-10.738924,"median":-8.890871,"eighty":-8.173221,"marketCap":9924216015},{"date":"2022-07-22","current":-8.295377,"twenty":-10.687772,"median":-8.843947,"eighty":-8.192495,"marketCap":9489420133},{"date":"2022-07-29","current":-7.886667,"twenty":-10.657029,"median":-8.819327,"eighty":-8.057303,"marketCap":9032884456},{"date":"2022-08-05","current":-7.136107,"twenty":-10.647839,"median":-8.783241,"eighty":-7.981108,"marketCap":8152422795},{"date":"2022-08-12","current":-7.088387,"twenty":-10.632543,"median":-8.711759,"eighty":-7.937979,"marketCap":8108943206},{"date":"2022-08-19","current":-8.891947,"twenty":-10.611473,"median":-8.651267,"eighty":-7.857437,"marketCap":8619828368},{"date":"2022-08-26","current":-9.878492,"twenty":-10.574914,"median":-8.756454,"eighty":-7.879762,"marketCap":9500290030},{"date":"2022-09-02","current":-9.641847,"twenty":-10.542686,"median":-8.8007,"eighty":-7.911799,"marketCap":9239412501},{"date":"2022-09-09","current":-8.585571,"twenty":-10.532235,"median":-8.776892,"eighty":-7.937979,"marketCap":8195902383},{"date":"2022-09-16","current":-8.205928,"twenty":-10.52923,"median":-8.711759,"eighty":-7.947262,"marketCap":7761106500},{"date":"2022-09-23","current":-7.850954,"twenty":-10.521509,"median":-8.645731,"eighty":-7.931397,"marketCap":7282831030},{"date":"2022-09-30","current":-6.666434,"twenty":-10.504967,"median":-8.625033,"eighty":-7.852429,"marketCap":6195841324},{"date":"2022-10-07","current":-6.701906,"twenty":-10.484881,"median":-8.591202,"eighty":-7.761108,"marketCap":6228451015},{"date":"2022-10-14","current":-7.35301,"twenty":-10.456108,"median":-8.583249,"eighty":-7.57143,"marketCap":6761075971},{"date":"2022-10-21","current":-7.951253,"twenty":-10.433151,"median":-8.545175,"eighty":-7.57143,"marketCap":7261091236},{"date":"2022-10-28","current":-6.796392,"twenty":-10.406061,"median":-8.508514,"eighty":-7.508003,"marketCap":6195841324},{"date":"2022-11-04","current":-6.754512,"twenty":-10.394357,"median":-8.473127,"eighty":-7.42644,"marketCap":6217581118},{"date":"2022-11-11","current":-6.097932,"twenty":-10.363764,"median":-8.469242,"eighty":-7.395321,"marketCap":5663216368},{"date":"2022-11-18","current":-6.753098,"twenty":-10.242234,"median":-8.45243,"eighty":-7.346759,"marketCap":6250190809},{"date":"2022-11-25","current":-6.736071,"twenty":-10.196623,"median":-8.439191,"eighty":-7.272097,"marketCap":6184971427},{"date":"2022-12-02","current":-7.773909,"twenty":-10.077914,"median":-8.37957,"eighty":-7.241589,"marketCap":7261091236},{"date":"2022-12-09","current":-8.002157,"twenty":-10.008085,"median":-8.295377,"eighty":-7.250791,"marketCap":7543708559},{"date":"2022-12-16","current":-7.535454,"twenty":-9.932205,"median":-8.278653,"eighty":-7.272097,"marketCap":7087172883},{"date":"2022-12-23","current":-7.51,"twenty":-9.898083,"median":-8.243002,"eighty":-7.316458,"marketCap":7065433089},{"date":"2022-12-30","current":-7.305703,"twenty":-9.88339,"median":-8.22445,"eighty":-7.296997,"marketCap":6956734118},{"date":"2023-01-06","current":-7.457393,"twenty":-9.877968,"median":-8.206319,"eighty":-7.311066,"marketCap":7174132059},{"date":"2023-01-13","current":-8.437239,"twenty":-9.858414,"median":-8.206709,"eighty":-7.320093,"marketCap":8271991662},{"date":"2023-01-20","current":-8.286606,"twenty":-9.834445,"median":-8.240006,"eighty":-7.327535,"marketCap":8054593721},{"date":"2023-01-27","current":-8.57561,"twenty":-9.827001,"median":-8.248307,"eighty":-7.330074,"marketCap":8337211045},{"date":"2023-02-03","current":-8.175491,"twenty":-9.75546,"median":-8.23701,"eighty":-7.341519,"marketCap":7989374339},{"date":"2023-02-10","current":-7.777299,"twenty":-9.742113,"median":-8.206319,"eighty":-7.345196,"marketCap":7554578456},{"date":"2023-02-17","current":-8.009725,"twenty":-9.697444,"median":-8.193537,"eighty":-7.35301,"marketCap":7706757015},{"date":"2023-02-24","current":-8.177484,"twenty":-9.647965,"median":-8.202583,"eighty":-7.359122,"marketCap":7771976397},{"date":"2023-03-03","current":-8.136456,"twenty":-9.641847,"median":-8.205928,"eighty":-7.362303,"marketCap":7782846294},{"date":"2023-03-10","current":-7.532958,"twenty":-7.936227,"median":-7.807589,"eighty":-7.663468,"marketCap":7152392265},{"date":"2023-03-17","current":-6.893844,"twenty":-29.280721,"median":-16.418697,"eighty":-8.337386,"marketCap":6608897412},{"date":"2023-03-24","current":-6.658655,"twenty":-29.278482,"median":-16.330752,"eighty":-8.295377,"marketCap":6456718853},{"date":"2023-03-31","current":-6.382321,"twenty":-29.265473,"median":-16.265645,"eighty":-8.279201,"marketCap":6141491838},{"date":"2023-04-06","current":-6.996826,"twenty":-29.261938,"median":-16.251298,"eighty":-8.277923,"marketCap":6728466280},{"date":"2023-04-14","current":-9.166043,"twenty":-29.244948,"median":-16.177122,"eighty":-8.278324,"marketCap":7282831030},{"date":"2023-04-21","current":-10.375279,"twenty":-29.156297,"median":-16.110434,"eighty":-8.280198,"marketCap":8239381971},{"date":"2023-04-28","current":-9.791172,"twenty":-28.966769,"median":-16.017528,"eighty":-8.284669,"marketCap":7717626912},{"date":"2023-05-05","current":-9.403412,"twenty":-28.879119,"median":-15.969405,"eighty":-8.286606,"marketCap":7424139691},{"date":"2023-05-12","current":-9.274529,"twenty":-28.852641,"median":-15.860307,"eighty":-8.292601,"marketCap":7271961133},{"date":"2023-05-19","current":-8.816242,"twenty":-28.781694,"median":-15.853497,"eighty":-8.295377,"marketCap":6815425456},{"date":"2023-05-25","current":-7.906691,"twenty":-28.683645,"median":-15.812226,"eighty":-8.286122,"marketCap":6087142353},{"date":"2023-06-02","current":-7.650251,"twenty":-28.635789,"median":-15.707766,"eighty":-8.27382,"marketCap":5869744412},{"date":"2023-06-09","current":-7.718055,"twenty":-28.62839,"median":-15.523719,"eighty":-8.241804,"marketCap":5913224000},{"date":"2023-06-16","current":-8.211383,"twenty":-28.539889,"median":-15.189066,"eighty":-8.211383,"marketCap":6261060706},{"date":"2023-06-23","current":-7.66872,"twenty":-28.479972,"median":-15.018009,"eighty":-8.206397,"marketCap":5815394927},{"date":"2023-06-30","current":-8.028021,"twenty":-28.434831,"median":-14.894025,"eighty":-8.185553,"marketCap":6032792868},{"date":"2023-07-07","current":-9.203166,"twenty":-28.42021,"median":-14.728988,"eighty":-8.185553,"marketCap":6902384633},{"date":"2023-07-14","current":-9.275907,"twenty":-28.374356,"median":-14.588335,"eighty":-8.192495,"marketCap":7054563191},{"date":"2023-07-21","current":-9.07511,"twenty":-28.325294,"median":-14.52296,"eighty":-8.195817,"marketCap":6869774941},{"date":"2023-07-28","current":-9.214207,"twenty":-28.276566,"median":-14.467488,"eighty":-8.201914,"marketCap":6967604015},{"date":"2023-08-04","current":-8.538775,"twenty":-28.107178,"median":-14.183362,"eighty":-8.20624,"marketCap":6467588750},{"date":"2023-08-11","current":-8.096561,"twenty":-27.877746,"median":-13.991007,"eighty":-8.191975,"marketCap":6098012250},{"date":"2023-08-18","current":-7.762464,"twenty":-27.830986,"median":-13.842305,"eighty":-8.175132,"marketCap":5804525030},{"date":"2023-08-25","current":-26.697795,"twenty":-27.784384,"median":-13.828395,"eighty":-8.158004,"marketCap":5837134721},{"date":"2023-09-01","current":-29.706597,"twenty":-28.107178,"median":-13.888892,"eighty":-8.170209,"marketCap":6521938236},{"date":"2023-09-08","current":-30.060486,"twenty":-28.420665,"median":-14.123754,"eighty":-8.173421,"marketCap":6521938236},{"date":"2023-09-15","current":-29.580626,"twenty":-28.629171,"median":-14.286381,"eighty":-8.175132,"marketCap":6467588750},{"date":"2023-09-22","current":-28.661921,"twenty":-28.647461,"median":-14.50559,"eighty":-8.176288,"marketCap":6239320912},{"date":"2023-09-29","current":-25.921048,"twenty":-28.629171,"median":-14.562003,"eighty":-8.182864,"marketCap":5652346471},{"date":"2023-10-06","current":-24.561986,"twenty":-28.613095,"median":-14.613721,"eighty":-8.191454,"marketCap":5353424302},{"date":"2023-10-13","current":-26.92125,"twenty":-28.546356,"median":-14.838741,"eighty":-8.194677,"marketCap":5858874515},{"date":"2023-10-20","current":-24.986856,"twenty":-28.505231,"median":-14.94306,"eighty":-8.200576,"marketCap":5429513581},{"date":"2023-10-27","current":-30.077169,"twenty":-28.55348,"median":-15.089723,"eighty":-8.205928,"marketCap":6532808133},{"date":"2023-11-03","current":-36.685816,"twenty":-28.661921,"median":-15.342423,"eighty":-8.206709,"marketCap":7989374339},{"date":"2023-11-10","current":-34.996098,"twenty":-28.781694,"median":-15.589929,"eighty":-8.211383,"marketCap":7619797839},{"date":"2023-11-17","current":139.007258,"twenty":-28.852641,"median":-15.556824,"eighty":-8.205928,"marketCap":8271991662},{"date":"2023-11-24","current":134.06759,"twenty":-28.781694,"median":-15.273067,"eighty":-8.177484,"marketCap":8043723824},{"date":"2023-12-01","current":123.410206,"twenty":-28.717643,"median":-15.018009,"eighty":-8.168722,"marketCap":7435009589},{"date":"2023-12-08","current":115.396674,"twenty":-28.676471,"median":-14.894025,"eighty":-8.136456,"marketCap":6924124427},{"date":"2023-12-15","current":112.572734,"twenty":-28.665909,"median":-14.728988,"eighty":-8.09843,"marketCap":6793685662},{"date":"2023-12-22","current":105.438504,"twenty":-28.661921,"median":-14.588335,"eighty":-8.0768,"marketCap":6358889780},{"date":"2023-12-29","current":124.600197,"twenty":-28.660248,"median":-14.542482,"eighty":-8.068487,"marketCap":7554578456},{"date":"2024-01-05","current":123.318541,"twenty":-28.647461,"median":-14.50559,"eighty":-8.040462,"marketCap":7424139691},{"date":"2024-01-12","current":129.388505,"twenty":-28.629171,"median":-14.286381,"eighty":-8.023906,"marketCap":7793716192},{"date":"2024-01-19","current":128.482233,"twenty":-28.598191,"median":-14.123754,"eighty":-8.004007,"marketCap":7728496809},{"date":"2024-01-26","current":127.895751,"twenty":-28.539232,"median":-13.888892,"eighty":-7.991336,"marketCap":7663277427},{"date":"2024-02-02","current":117.16038,"twenty":-28.492602,"median":-13.828395,"eighty":-7.968917,"marketCap":7011083603},{"date":"2024-02-09","current":116.043963,"twenty":-28.441459,"median":-13.741036,"eighty":-7.955731,"marketCap":6978473912},{"date":"2024-02-16","current":117.464597,"twenty":-28.421577,"median":-13.690402,"eighty":-7.951253,"marketCap":7065433089},{"date":"2024-02-23","current":117.542093,"twenty":-28.419298,"median":-13.613328,"eighty":-7.941856,"marketCap":7032823397},{"date":"2024-03-01","current":119.647539,"twenty":-28.344394,"median":-13.512101,"eighty":-7.915092,"marketCap":7163262162},{"date":"2024-03-08","current":126.672019,"twenty":-28.296644,"median":-13.425131,"eighty":-7.869405,"marketCap":7587188147},{"date":"2024-03-15","current":136.411129,"twenty":-28.24645,"median":-13.3476,"eighty":-7.842873,"marketCap":8163292692},{"date":"2024-03-22","current":12.973937,"twenty":-28.044189,"median":-13.218965,"eighty":-7.777299,"marketCap":7695887118},{"date":"2024-03-28","current":12.519209,"twenty":-28.009087,"median":-13.100065,"eighty":-7.772172,"marketCap":7402399897},{"date":"2024-04-05","current":13.37366,"twenty":-27.959496,"median":-13.038286,"eighty":-7.76525,"marketCap":7902415162},{"date":"2024-04-12","current":13.568308,"twenty":-27.877746,"median":-12.982107,"eighty":-7.733431,"marketCap":8021984030},{"date":"2024-04-19","current":13.635105,"twenty":-27.845088,"median":-12.954555,"eighty":-7.711179,"marketCap":8054593721},{"date":"2024-04-26","current":15.199524,"twenty":-27.834055,"median":-12.900046,"eighty":-7.66971,"marketCap":8967665074},{"date":"2024-05-03","current":15.30222,"twenty":-27.818775,"median":-12.756941,"eighty":-7.639641,"marketCap":9022014559},{"date":"2024-05-10","current":15.81776,"twenty":-27.795706,"median":-12.554537,"eighty":-7.60133,"marketCap":9348111471},{"date":"2024-05-17","current":16.559383,"twenty":-27.750416,"median":-12.52579,"eighty":-7.583293,"marketCap":9772037456},{"date":"2024-05-24","current":17.391151,"twenty":-27.748227,"median":-12.491199,"eighty":-7.548422,"marketCap":10239443030},{"date":"2024-05-31","current":17.373469,"twenty":-27.745702,"median":-12.342599,"eighty":-7.532958,"marketCap":10239443030},{"date":"2024-06-07","current":17.395042,"twenty":-27.698671,"median":-12.324879,"eighty":-7.475268,"marketCap":10239443030},{"date":"2024-06-14","current":17.410995,"twenty":-27.635676,"median":-12.220722,"eighty":-7.447557,"marketCap":10239443030},{"date":"2024-06-21","current":17.44752,"twenty":-27.579411,"median":-12.146878,"eighty":-7.429881,"marketCap":10239443030},{"date":"2024-06-28","current":21.169921,"twenty":-27.531991,"median":-12.107468,"eighty":-7.409463,"marketCap":12418857391},{"date":"2024-07-05","current":21.31352,"twenty":-27.509142,"median":-12.073098,"eighty":-7.391342,"marketCap":12500381619},{"date":"2024-07-12","current":20.958398,"twenty":-27.436,"median":-12.028963,"eighty":-7.356677,"marketCap":12310158420},{"date":"2024-07-19","current":20.772946,"twenty":-27.320477,"median":-12.010321,"eighty":-7.327535,"marketCap":12201459449},{"date":"2024-07-26","current":20.696058,"twenty":-27.195166,"median":-11.942483,"eighty":-7.298439,"marketCap":12201459449},{"date":"2024-08-02","current":20.846486,"twenty":-27.093894,"median":-11.893713,"eighty":-7.252794,"marketCap":12282983677},{"date":"2024-08-09","current":20.754283,"twenty":-27.015113,"median":-11.837535,"eighty":-7.211803,"marketCap":12310158420},{"date":"2024-08-16","current":21.066803,"twenty":-26.967771,"median":-11.806904,"eighty":-7.168418,"marketCap":12500381619},{"date":"2024-08-23","current":20.886927,"twenty":-26.955307,"median":-11.609004,"eighty":-7.109109,"marketCap":12446032133},{"date":"2024-08-30","current":16.43423,"twenty":-26.948522,"median":-11.548619,"eighty":-6.995646,"marketCap":12500381619},{"date":"2024-09-06","current":16.533448,"twenty":-26.930541,"median":-11.45821,"eighty":-6.871599,"marketCap":12581905846},{"date":"2024-09-13","current":16.576841,"twenty":-26.803138,"median":-11.259414,"eighty":-6.79064,"marketCap":12581905846},{"date":"2024-09-20","current":16.406845,"twenty":-26.713756,"median":-11.226983,"eighty":-6.778362,"marketCap":12527556361},{"date":"2024-09-27","current":16.0965,"twenty":-26.474991,"median":-11.12377,"eighty":-6.734055,"marketCap":12364507905},{"date":"2024-10-04","current":16.063334,"twenty":-26.12212,"median":-11.064322,"eighty":-6.695364,"marketCap":12282983677},{"date":"2024-10-10","current":16.275333,"twenty":-25.921214,"median":-11.005246,"eighty":-6.664268,"marketCap":12364507905},{"date":"2024-10-18","current":16.144897,"twenty":-25.637712,"median":-10.902857,"eighty":-6.619301,"marketCap":12201459449},{"date":"2024-10-25","current":15.534605,"twenty":-25.112408,"median":-10.861622,"eighty":-6.595078,"marketCap":11739488824},{"date":"2024-11-01","current":15.739753,"twenty":-24.881781,"median":-10.769967,"eighty":-6.445564,"marketCap":11902537280},{"date":"2024-11-08","current":15.16169,"twenty":-24.562552,"median":-10.648314,"eighty":-6.336141,"marketCap":11413391913},{"date":"2024-11-15","current":14.703704,"twenty":-23.751057,"median":-10.532504,"eighty":12.609275,"marketCap":10951421287},{"date":"2024-11-22","current":14.783679,"twenty":-23.53783,"median":-10.449772,"eighty":13.062987,"marketCap":11005770773},{"date":"2024-11-29","current":15.706785,"twenty":-22.999838,"median":-10.31116,"eighty":13.490644,"marketCap":11685139339},{"date":"2024-12-06","current":16.219845,"twenty":-22.435947,"median":-10.035329,"eighty":13.731242,"marketCap":12038410993},{"date":"2024-12-13","current":16.288608,"twenty":-22.216491,"median":-9.890736,"eighty":14.555832,"marketCap":12065585736},{"date":"2024-12-20","current":17.613984,"twenty":-22.004449,"median":-9.806112,"eighty":14.82169,"marketCap":12989526986},{"date":"2024-12-27","current":17.627659,"twenty":-21.549335,"median":-9.748786,"eighty":14.920514,"marketCap":12989526986},{"date":"2025-01-03","current":17.426208,"twenty":-21.059501,"median":-9.644906,"eighty":15.101644,"marketCap":12853653273},{"date":"2025-01-10","current":17.15965,"twenty":-20.607327,"median":-9.566598,"eighty":15.217942,"marketCap":12609080589},{"date":"2025-01-17","current":14.05661,"twenty":-20.35213,"median":-9.486199,"eighty":15.260472,"marketCap":10337272104},{"date":"2025-01-24","current":11.824511,"twenty":-20.071108,"median":-9.37996,"eighty":15.260472,"marketCap":8750267133},{"date":"2025-01-28","current":12.245071,"twenty":-20.059273,"median":-9.37213,"eighty":15.246556,"marketCap":9108973736},{"date":"2025-02-07","current":14.732138,"twenty":-19.881739,"median":-9.29934,"eighty":15.274388,"marketCap":10897071802},{"date":"2025-02-14","current":15.503935,"twenty":-19.716064,"median":-9.259788,"eighty":15.394257,"marketCap":11440566655},{"date":"2025-02-21","current":15.602496,"twenty":-19.58997,"median":-9.203166,"eighty":15.430255,"marketCap":11576440368},{"date":"2025-02-28","current":20.173929,"twenty":-19.487135,"median":-9.138682,"eighty":15.600316,"marketCap":14918933714},{"date":"2025-03-07","current":22.691836,"twenty":-19.370014,"median":-9.081498,"eighty":15.678831,"marketCap":16848340443},{"date":"2025-03-14","current":22.646997,"twenty":-19.065782,"median":-8.992114,"eighty":15.77216,"marketCap":16821165700},{"date":"2025-03-21","current":22.326485,"twenty":-18.982567,"median":-8.937842,"eighty":15.869892,"marketCap":16576593016},{"date":"2025-03-28","current":21.446687,"twenty":-18.934089,"median":-8.881066,"eighty":15.958854,"marketCap":18832096656},{"date":"2025-04-03","current":20.496847,"twenty":-18.839523,"median":-8.833895,"eighty":16.064644,"marketCap":17962504891},{"date":"2025-04-11","current":17.855677,"twenty":-18.683014,"median":-8.776892,"eighty":16.101901,"marketCap":15543952795},{"date":"2025-04-17","current":21.145085,"twenty":-18.601961,"median":-8.681154,"eighty":16.211906,"marketCap":18451650259},{"date":"2025-04-25","current":23.553782,"twenty":-18.443201,"median":-8.6186,"eighty":16.246671,"marketCap":20571280186},{"date":"2025-05-02","current":25.056257,"twenty":-18.421123,"median":-8.595918,"eighty":16.285953,"marketCap":21930017318},{"date":"2025-05-09","current":21.736701,"twenty":-18.357986,"median":-8.578328,"eighty":16.307243,"marketCap":19158193568},{"date":"2025-05-16","current":24.221218,"twenty":-18.226089,"median":-8.538775,"eighty":16.352589,"marketCap":21522396178},{"date":"2025-05-23","current":25.67354,"twenty":-18.094256,"median":-8.474772,"eighty":16.43423,"marketCap":22881133311},{"date":"2025-05-30","current":28.32371,"twenty":-18.042007,"median":-8.459142,"eighty":16.529212,"marketCap":25354034892},{"date":"2025-06-06","current":27.615744,"twenty":-18.001357,"median":-8.448171,"eighty":16.543914,"marketCap":24783365296},{"date":"2025-06-13","current":28.93664,"twenty":-17.933569,"median":-8.429191,"eighty":16.59113,"marketCap":25979053973},{"date":"2025-06-20","current":29.114781,"twenty":-17.88088,"median":-8.326656,"eighty":16.663735,"marketCap":26087752944},{"date":"2025-06-27","current":30.394421,"twenty":-17.812992,"median":-8.289604,"eighty":17.360329,"marketCap":27310616363},{"date":"2025-07-04","current":33.810314,"twenty":-17.801509,"median":-8.277953,"eighty":17.373683,"marketCap":30381362282},{"date":"2025-07-11","current":31.664802,"twenty":-17.567437,"median":-8.248047,"eighty":17.392581,"marketCap":28424780811},{"date":"2025-07-18","current":38.172983,"twenty":-17.446462,"median":-8.211383,"eighty":17.398695,"marketCap":34240175739},{"date":"2025-07-25","current":37.581872,"twenty":-17.327692,"median":-8.192235,"eighty":17.415819,"marketCap":33832554599},{"date":"2025-08-01","current":40.093578,"twenty":-17.167788,"median":-8.170581,"eighty":17.4341,"marketCap":35870660298},{"date":"2025-08-08","current":44.992727,"twenty":-17.097162,"median":-8.121718,"eighty":17.480128,"marketCap":40354492835},{"date":"2025-08-15","current":50.734499,"twenty":-17.058582,"median":-8.093911,"eighty":17.621631,"marketCap":45436169710},{"date":"2025-08-22","current":50.833217,"twenty":-16.859598,"median":-8.068042,"eighty":18.705535,"marketCap":45381820225},{"date":"2025-08-29","current":46.979642,"twenty":-16.745455,"median":-8.037018,"eighty":20.138159,"marketCap":42338249048},{"date":"2025-09-05","current":49.410758,"twenty":-16.617085,"median":-8.00783,"eighty":20.53569,"marketCap":44485053718},{"date":"2025-09-12","current":47.905886,"twenty":-16.339663,"median":-7.991861,"eighty":20.742638,"marketCap":43207840813},{"date":"2025-09-19","current":46.794173,"twenty":-16.219396,"median":-7.96845,"eighty":20.789539,"marketCap":42175200592},{"date":"2025-09-26","current":43.258153,"twenty":-16.026591,"median":-7.951507,"eighty":20.858338,"marketCap":38887056732},{"date":"2025-10-03","current":44.331295,"twenty":-15.928376,"median":-7.944262,"eighty":20.881711,"marketCap":39946871695},{"date":"2025-10-10","current":43.248336,"twenty":-15.847839,"median":-7.921823,"eighty":20.912054,"marketCap":38914231474},{"date":"2025-10-17","current":43.312255,"twenty":-15.64105,"median":-7.867054,"eighty":20.962367,"marketCap":38941406217},{"date":"2025-10-24","current":42.027527,"twenty":-15.101997,"median":-7.840525,"eighty":21.030606,"marketCap":37800067026},{"date":"2025-10-31","current":42.145948,"twenty":-14.892482,"median":-7.774922,"eighty":21.062977,"marketCap":37963115482},{"date":"2025-11-07","current":36.889434,"twenty":-14.583069,"median":-7.760491,"eighty":21.163007,"marketCap":33207535518},{"date":"2025-11-14","current":40.397492,"twenty":-14.413417,"median":-7.721802,"eighty":21.238988,"marketCap":36468504636},{"date":"2025-11-21","current":38.428633,"twenty":-13.89831,"median":-7.676709,"eighty":21.585681,"marketCap":34674971621},{"date":"2025-11-28","current":41.440339,"twenty":-13.752396,"median":-7.636297,"eighty":22.072269,"marketCap":37528319599},{"date":"2025-12-05","current":40.470534,"twenty":-13.594758,"median":-7.584132,"eighty":22.535186,"marketCap":36713077320},{"date":"2025-12-10","current":39.352109,"twenty":-13.507065,"median":-7.563995,"eighty":22.81753,"marketCap":35734786584}],"updateTime":1765421205887},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02696\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588208532","title":"Shanghai Henlius' IND Application for Cancer Therapy Gains China Approval; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588208532","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588208532?lang=en_us&edition=fundamental","pubTime":"2025-12-02 11:31","pubTimestamp":1764646302,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech  said China's National Medical Products Administration has approved its investigational new drug application for HLX37, a humanised anti-PD-L1 and anti-VEGF bispecific antibody, according to a Monday filing.Shares of the pharmaceutical company were down nearly 3% in Tuesday morning trade.HLX37, developed in-house, is intended to treat advanced or metastatic solid tumours by simultaneously blocking PD-L1-mediated immunosuppression and VEGF-driven tumour angiogenesis, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IND","02696","HK0000165453.HKD","BK1161"],"gpt_icon":0},{"id":"1171810993","title":"Shanghai Henlius Biotech (2696) Announces IND Approval for HLX37 Bispecific Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=1171810993","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171810993?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:26","pubTimestamp":1764581176,"startTime":"0","endTime":"0","summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim all responsibility for the contents of this announcement and make no representation as to its accuracy or...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"gpt_icon":0},{"id":"1139887921","title":"HENLIUS (02696) Receives NMPA Approval for Phase 1 Clinical Trial of Self-Developed HLX37 in Advanced/Metastatic Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1139887921","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139887921?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:16","pubTimestamp":1764580573,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that its self-developed HLX37 (a recombinant humanized anti-PD-L1 and anti-VEGF bispecific antibody injection) has received approval from the National Medical Products...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1161","02696"],"gpt_icon":0},{"id":"2588728412","title":"Shanghai Henlius Biotech Inc - Nmpa Approves Ind Application for Hlx37 in Advanced Solid Tumours","url":"https://stock-news.laohu8.com/highlight/detail?id=2588728412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588728412?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:11","pubTimestamp":1764580319,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X701K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000165453.HKD","BK1161","02696"],"gpt_icon":0},{"id":"1137757394","title":"Taikang Life Insurance Increases Stake in HENLIUS, Marking 37th Insurance Capital \"Intervention\" This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1137757394","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137757394?lang=en_us&edition=fundamental","pubTime":"2025-11-28 20:51","pubTimestamp":1764334293,"startTime":"0","endTime":"0","summary":"Insurance capital is accelerating its stake acquisitions. On November 26, Taikang Life Insurance disclosed an announcement regarding its increased stake in HENLIUS H-shares. The company purchased...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","02696","BK1161"],"gpt_icon":0},{"id":"2586880902","title":"Shanghai Henlius Biotech (SEHK:2696): Evaluating Current Valuation Following Recent Share Price Fluctuations","url":"https://stock-news.laohu8.com/highlight/detail?id=2586880902","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586880902?lang=en_us&edition=fundamental","pubTime":"2025-11-26 07:16","pubTimestamp":1764112571,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (SEHK:2696) shares have seen some movement recently, prompting investors to take a closer look at the company’s recent performance. A quick glance shows mixed returns over the past month and quarter.\nSee our latest analysis for Shanghai Henlius Biotech.\nShanghai Henlius Biotech’s share price has cooled off lately, but momentum over the past year has been exceptional. The company delivered a 225% total shareholder return, which signals strong growth sentiment and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-evaluating-current-valuati","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-evaluating-current-valuati","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000165453.HKD","DCF","BK1161","02696"],"gpt_icon":0},{"id":"2586547346","title":"Henlius Biotech Doses First Patient in Hepatocellular Carcinoma Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2586547346","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586547346?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:01","pubTimestamp":1764075675,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (HKG:2696) dosed the first patient in international multicenter phase 1 clinical study of Ipilimumab biosimilar HLX13 in mainland China, a Tuesday Hong Kong bourse filing said.The drug is for the first-line treatment of patients with unresectable hepatocellular carcinoma.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","HK0000165453.HKD","02696"],"gpt_icon":0},{"id":"1192467692","title":"Taikang Insurance Group, Inc. Increases Stake in HENLIUS (02696) by 518,500 Shares at HK$67.07 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1192467692","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192467692?lang=en_us&edition=fundamental","pubTime":"2025-11-25 19:06","pubTimestamp":1764068787,"startTime":"0","endTime":"0","summary":"According to the latest disclosure from the Hong Kong Stock Exchange, Taikang Insurance Group, Inc. acquired an additional 518,500 shares of HENLIUS (02696) on November 20 at HK$67.0678 per share,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161","HK0000165453.HKD"],"gpt_icon":0},{"id":"1122838052","title":"Shanghai Henlius Biotech (2696) Announces First Patient Dosed in Phase 1 Trial of HLX13 for Unresectable HCC","url":"https://stock-news.laohu8.com/highlight/detail?id=1122838052","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122838052?lang=en_us&edition=fundamental","pubTime":"2025-11-25 16:44","pubTimestamp":1764060247,"startTime":"0","endTime":"0","summary":"On 25 November 2025, Shanghai Henlius Biotech (2696) announced that the first patient in Mainland China had been dosed in an international multicenter Phase 1 clinical study of HLX13 (Ipilimumab...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"gpt_icon":0},{"id":"1118435898","title":"HENLIUS (02696): First Patient Dosed in China for International Phase 1 Clinical Study of HLX13 (Ipilimumab Biosimilar) in First-Line Treatment of Unresectable Hepatocellular Carcinoma (HCC)","url":"https://stock-news.laohu8.com/highlight/detail?id=1118435898","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118435898?lang=en_us&edition=fundamental","pubTime":"2025-11-25 16:36","pubTimestamp":1764059807,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that the first patient in China has been dosed in its international multicenter Phase 1 clinical study for HLX13 (recombinant fully human anti-CTLA-4 monoclonal antibody...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","HK0000165453.HKD","HCC","02696","BK1161"],"gpt_icon":0},{"id":"1153166979","title":"HK Stock Movement | HENLIUS (02696) Rises Over 6% in Afternoon Session as Serplulimab Included in NMPA's Breakthrough Therapy List","url":"https://stock-news.laohu8.com/highlight/detail?id=1153166979","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153166979?lang=en_us&edition=fundamental","pubTime":"2025-11-24 15:14","pubTimestamp":1763968458,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) surged more than 6% in the afternoon session, with gains narrowing to 4.94% by the time of writing, trading at HK$66.95 and recording a turnover of HK$63.14 million. The company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000165453.HKD","02696"],"gpt_icon":0},{"id":"1157079242","title":"US September Nonfarm Payrolls Exceed Expectations, Third Rate Cut This Year Unlikely","url":"https://stock-news.laohu8.com/highlight/detail?id=1157079242","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157079242?lang=en_us&edition=fundamental","pubTime":"2025-11-21 07:50","pubTimestamp":1763682632,"startTime":"0","endTime":"0","summary":"【Top Story】Innovent Biologics (01801): Obesity Drug Meets Primary Endpoint in Phase 3 Trial, Plans to Submit MASHITIDE 9mg for Approval   Innovent Biologics announced that its global first-in-class...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3d776d860091c121dc4a4735cfb272f5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGUmain","HK0000165453.HKD","DUST","GDX","SGCmain","GCmain","MGCmain","GLD","159934","518880","BK1161","NUGT","IAU","02696","02565","SImain"],"gpt_icon":1},{"id":"1125215211","title":"HENLIUS (02696): Hansizhuang® (Serplulimab Injection) Combined with Chemotherapy for Gastric Cancer Neoadjuvant/Adjuvant Therapy Officially Included in NMPA's Breakthrough Therapy Designation Program","url":"https://stock-news.laohu8.com/highlight/detail?id=1125215211","media":"Stock News","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125215211?lang=en_us&edition=fundamental","pubTime":"2025-11-20 16:56","pubTimestamp":1763628982,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that Hansizhuang® (Serplulimab Injection) combined with chemotherapy for neoadjuvant/adjuvant treatment of gastric cancer has been officially included in the Breakthrough...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696","HK0000165453.HKD"],"gpt_icon":0},{"id":"2584956181","title":"Shanghai Henlius Biotech Receives Breakthrough Therapy Designation for HANSIZHUANG in Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584956181","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584956181?lang=en_us&edition=fundamental","pubTime":"2025-11-20 16:50","pubTimestamp":1763628629,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech Inc. announced that its product HANSIZHUANG , in combination with chemotherapy, has been officially granted Breakthrough Therapy Designation by the Center for Drug Evaluation of the National Medical Products Administration  for the neo-/adjuvant treatment of gastric cancer. This designation is expected to accelerate the regulatory review and market approval process for HANSIZHUANG. As of the announcement date, no other monoclonal antibody drug targeting PD-1 has received global approval for this indication. There is no indication that this grant was obtained by multiple organizations; it is specific to Shanghai Henlius Biotech Inc.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. pub","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL7CTkYn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656","BK1230","HK0000165453.HKD","02696","BK1161"],"gpt_icon":0},{"id":"2584181568","title":"Shanghai Henlius Biotech - Hansizhuang Granted Breakthrough Therapy Designation for Gastric Cancer by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2584181568","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584181568?lang=en_us&edition=fundamental","pubTime":"2025-11-20 16:47","pubTimestamp":1763628439,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WV1GE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02696","HK0000165453.HKD"],"gpt_icon":0},{"id":"1138286818","title":"Hong Kong Stocks Movement | HENLIUS (02696) Rises Over 4% as POHERDY Gains U.S. Approval, Covering All Indications of Reference Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1138286818","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138286818?lang=en_us&edition=fundamental","pubTime":"2025-11-20 11:00","pubTimestamp":1763607621,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) surged over 4%, reaching HK$67.1 by the time of writing, with a trading volume of HK$31.4 million. The company, in collaboration with Organon, announced that the Biologics License...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161","HK0000165453.HKD"],"gpt_icon":0},{"id":"2584408076","title":"Organon, Shanghai Henlius Biotech Says FDA Clears Poherdy as Pertuzumab Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2584408076","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584408076?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:44","pubTimestamp":1763379894,"startTime":"0","endTime":"0","summary":"Organon  and Shanghai Henlius Biotech said Monday that the US Food and Drug Administration has approved the biologics license application for Poherdy as an \"interchangeable biosimilar\" to Perjeta, also known as pertuzumab.The companies said Poherdy is indicated for use in combination with trastuzumab and docetaxel for the treatment of adults with HER2-positive metastatic breast cancer, and in combination with trastuzumab and chemotherapy as a neoadjuvant treatment for adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer.Organon has a 2022 license deal with Shanghai Henlius Biotech, covering exclusive commercialization rights to Poherdy and other biosimilars, according to the statement.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02696","LU2065171402.SGD","LU2065170008.USD","BK4007","BK4559","OGN","BK4585","BK4588","LU2065169927.USD","BK1161","HK0000165453.HKD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2584429376","title":"BUZZ-Organon rises after US FDA clears first biosimilar for breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2584429376","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584429376?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:08","pubTimestamp":1763377714,"startTime":"0","endTime":"0","summary":"BUZZ-Organon rises after US FDA clears first biosimilar for breast cancer** Shares of healthcare firm Organon OGN.N rise 4.65% to $7.88 premarket** Co and Shanghai Henlius Biotech say US FDA approves their breast cancer drug Poherdy** The two companies' Poherdy first biosimilar to rival Roche's ROG.S Perjeta for HER2-positive breast cancer - OGN** Co says drug to be used with other therapies for advanced or early-stage breast cancer; Organon to market in U.S - OGN** Poherdy carries warnings for heart issues and birth defects; doctors advised to monitor patients, co says** Up to last close, stock down ~50% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nL4N3WT0P0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065170008.USD","00656","BK4559","BK4588","BK1230","BK4585","02696","HK0000165453.HKD","BK1161","LU2065171311.SGD","BK4007","LU2065169927.USD","OGN"],"gpt_icon":0},{"id":"2584010641","title":"FDA Approves Organon and Henlius' POHERDY as First Perjeta Biosimilar in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2584010641","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584010641?lang=en_us&edition=fundamental","pubTime":"2025-11-17 18:30","pubTimestamp":1763375433,"startTime":"0","endTime":"0","summary":"Organon & Co. and Shanghai Henlius Biotech, Inc. have announced that the US Food and Drug Administration  has approved the Biologics License Application for POHERDY , an interchangeable biosimilar to PERJETA . POHERDY is the first and only approved pertuzumab biosimilar in the US and is indicated for all uses of the reference product, expanding access to potentially more affordable biologic therapies for patients with certain HER2-positive breast cancers. This approval follows an agreement between Henlius and Organon granting Organon exclusive global commercialization rights to POHERDY, except in China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via Busin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL7M1FWn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD","BK4007","BK4588","HK0000165453.HKD","BK1230","OGN","BK1161","BK4559","BK4585","LU2065171311.SGD","00656","02696"],"gpt_icon":0},{"id":"2583574990","title":"Henlius Biotech Gets US FDA Nod for Breast Cancer Drug's Biologics License Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2583574990","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583574990?lang=en_us&edition=fundamental","pubTime":"2025-11-14 18:07","pubTimestamp":1763114852,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech  obtained approval for the biologics license application of POHERDY injection for intravenous use from the US Food and Drug Administration , a Friday Hong Kong bourse filing said.The approved indications include use in combination with trastuzumab and chemotherapy in the treatment of adults with breast cancer.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","HK0000165453.HKD","02696"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":146,"code":"91000000","status":"200"}]}}